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 Genes of the Sox family of HMG-transcription factors are essential during nervous 
system development. Here, we show that Sox5 is expressed by neural progenitors 
in the chick spinal cord and is turned off as differentiation proceeds. Over-
expression of Sox5 in neural progenitors causes premature cell cycle exit and 
prevents terminal differentiation. Conversely, knocking down Sox5 protein 
extends the proliferative period of neural progenitors and causes dramatic cell 
death in a dorsal interneuron (dI3) population. Moreover, Sox5 reduces Wnt/β-
catenin signalling triggering the expression of the negative regulator of the 
pathway Axin2. We propose that Sox5 regulates the timing of cell cycle exit by 
opposing Wnt/β-catenin activity on cell cycle progression. 
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INTRODUCTION  
During the development of the central nervous system (CNS), a large number of 
different neurons and glial cells are generated from a small population of self-renewing 
stem and progenitor cells. In the vertebrate spinal cord mitotically active and 
postmitotic cell populations are spatially segregated. Thus, neural progenitors are 
located in the medial ventricular zone and they migrate laterally to the mantle zone upon 
exiting the cell cycle, a site where differentiating cells accumulate.  
A dorsal-ventral gradient of the Wnt /-catenin/Tcf pathway positively regulates cell 
cycle progression of spinal neural progenitors through CyclinD1, CyclinD2 and Nmyc 
(Megason & McMahon, 2002).  
However, it is still not clear how the progression of the proliferation programme, 
promoted by signals like Wnt, can be counteracted to facilitate the initiation of the 
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neurogenic programme. The HMG-box transcription factors of the Sox gene family 
could be at the core of some of those processes, as they have essential regulatory 
functions during neurogenesis in the CNS (Wegner & Stolt, 2005). In the spinal cord, 
Sox1-3 proteins (SoxB1 group) preserve cells in an undifferentiated state (Bylund et al, 
2003). By contrast, SoxB2 factors promote the initiation of the differentiation 
programme (Sandberg et al, 2005). Sox5 belongs to the SoxD group and it is involved 
in the formation of the cephalic neural crest (Perez-Alcala et al, 2004), as well as in the 
control of the cell fate of distinct corticofugal neurons (Lai et al, 2008).  
Here, we show that Sox5 is expressed in neural progenitors in the spinal cord, and in 
dorsal dI3 interneurons. Through gain- and loss-of-function analyses, we found that 
Sox5 controls the timing of cell cycle exit by neural progenitors at the G1-S transition 
by counteracting the mitotic effect of the Wnt/β-catenin pathway. We provide evidence 
to suggest that Sox5 does this by controlling the feedback repressor pathway regulating 
Wnt signalling. Furthermore, we have found that Sox5 downregulation in postmitotic 
cells is necessary for the progression of the differentiation program. Hence, these data 
situate Sox5 as an important brake of Wnt/β-catenin mitogenic activity during the 
progression of neurogenesis.  
 
RESULTS AND DISCUSSION 
Sox5 is expressed in neural progenitors in the spinal cord and in a subset of 
interneurons and motoneurons 
In order to determine the possible role of Sox5 in early neurogenesis, we defined the 
pattern of Sox5 expression at the midtrunk level of the spinal cord in chicken embryos 
at stages 10-24 of Hamburguer and Hamilton (HH10-24). At HH10, when most of the 
neuroepithelial cells are proliferating progenitors, very low levels of Sox5 were detected 
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in these progenitors whereas higher levels were observed in the dorsal premigratory 
neural crest cells (Fig 1A). By HH14, when around 12% of the neural progenitors have 
exited the cell cycle and have started differentiation at the marginal zone (Wilcock et al, 
2007), Sox5 expression increased in progenitors (Fig 1B). Finally, from HH14 to HH24, 
when neural differentiation is more active and gliogenesis has not yet started, Sox5 
expression disappeared from most of the interneurons that expressed the pan-neural 
marker HuC/D (Fig 1C,D). At HH24, Sox5 expression remained in neural progenitors 
expressing Pax7 (Fig 1E,F). Dorsally, only Islet1/2+ dorsal interneurons (dI3) expressed 
Sox5 (Fig 1G-I). Ventrally, Sox5 was expressed by a small subpopulation of the 
Islet1/2+ motoneurons (Fig 1J-L). This dynamic pattern of expression suggests a 
possible role for Sox5 in the control of the transition from proliferation to 
differentiation. 
 
Sox5 controls the timing of cell cycle exit  
To explore the function of Sox5 in neurogenesis, we electroporated a pCAGGS-Sox5-
IRES-GFP vector (pCIG-Sox5) and prematurely increased Sox5 levels (Sox5HIGH) in 
neural progenitors at stage HH10-13. Sox5HIGH provoked a 30.6±3.3 % decrease in the 
size of the electroporated right hemi-tube 24 hours post electroporation (PE; stage 
HH14-17) when compared to the left control side (Fig 2E; supplementary Table1) or 
with an electroporated control neural tube (pCIG; Fig 2A). There were not significant 
changes in cell density in Sox5 electroporated neural tubes (supplementary Table1). The 
change in the hemitube size was due, in part, to a substantial decrease in proliferation 
observed by a reduction in BrdU incorporation after a 40 min pulse (only 61% ± 11 
incorporated BrdU; Fig 2 F,B,I) and in the number of cells in M phase expressing 
phospho-Histone H3 (PH3; only 73±13%; Fig 2G,C,I) in comparison with control 
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embryos. This reduction was even more dramatic 48 hours PE (at HH19-23) when the 
proportion of PH3+ cells decreased to 46±7% (Fig 2I) and that of BrdU+ cells fell to 
59±9% (Fig 2I). The reduction in proliferation in Sox5HIGH cells was accompanied by an 
increase in apoptosis 24 hours (260±20%; Fig 2I and supplementary Fig 1D) and 48 
hours PE (314±114%; Fig 2I) in relation to control cells (Fig 2I and supplementary Fig 
1A). Consequently, a premature increase in Sox5 reduces the total number of 
neuroepithelial cells due to both a reduction in cell proliferation and activation of 
apoptosis. 
To further explore if the neural cells with Sox5HIGH had an altered cell cycle 
phenotype and not only an increased death rate, we analysed the cell cycle distribution 
of surviving cells by flow cytometry. After 24 h of Sox5 electroporation, the ratio of 
neuroepithelial cells accumulated in G0/G1 phases was increased by 23% with respect 
to control electroporated cells in G0/G1 (a 10% increase respect to the total population; 
supplementary Fig 2A,B). In accordance, the expression of CyclinD1 and Nmyc were 
severely reduced in neural progenitors (Fig 3H; data not shown). 
To clarify if neural progenitors overexpressing Sox5 were exiting the cell cycle 
(accumulated in G0) or retained in a longer G1 phase due to the reduction in CyclinD1 
levels (Lange et al 2009), cumulative BrdU labelling was performed (Nowakowski et 
al, 1989; Fig 2J). We found that Sox5HIGH neural progenitors had a similar cell cycle 
length to pCIG control progenitors (14.8 and 14.4 hr, respectively) and similar S phase 
duration (4.5 and 4.7 hr respectively). However, there was a 12% decrease in the 
proportion of Sox5HIGH cycling cells respect to the control (growth fraction of 0.75±0.03 
versus 0.85±0.05; Fig 2J). In conclusion, Sox5 promotes premature cell cycle exit in 
neural progenitors without significantly affecting cell cycle length. 
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As for the increase in apoptosis, we have found that while 53±8% of the pCIG 
apoptotic cells were BrdU+ progenitors (after a 2 hr pulse), only a 28±6% of the 
Sox5HIGH apoptotic cells were BrdU+. Additionally, there were no changes in the 
number of apoptotic cells that expressed the differentiation marker HuC/D (15±6% for 
the pCIG and 13±4% for the Sox HIGH apoptotic cells; data not shown). Moreover, using 
the Bcl2 survival factor to rescue this cell death (Cayuso et al, 2006; supplementary Fig 
1B-G), we observed that neuroepithelial cells with high levels of Sox5+Bcl2 
preferentially accumulated at G0/G1 (38% increase; supplementary Fig 2C,D). Thus, 
apoptosis caused by Sox5 overexpression predominantly occurs in postmitotic neural 
cells before they acquire definitive neuronal markers. 
We next addressed whether Sox5 was not only sufficient but was also necessary to 
control the balance of cell proliferation-cell cycle exit. Knocking down Sox5 expression 
by specific interfering short hairpin RNAs (pRFPRNAi-Sox5) caused a dramatic 66±4% 
reduction in Sox5 protein levels 48 hours PE at HH19-22 (Fig 3A-B; supplementary Fig 
3A). Neural progenitors with reduced Sox5 levels, upon using two different interferent 
RNAs (mi1 and mi2), presented a higher frequency of both BrdU incorporation (up to 
114±7%; Fig 3D,C,G) and PH3 staining (up to 130±19%; Fig 3 E-G). Moreover, a 
small number of cells transfected with RNAi-Sox5 and expressing PH3 were located in 
the mantle layer (insets in Fig 3F), suggesting that they entered mitosis in an ectopic 
position. In fact, reducing Sox5 levels increased CyclinD1 expression (n=3; Fig 3I). 
That could account for the appearance of ectopic mitosis as long-term forced expression 
of CyclinD1 leads to the appearance of proliferating cells in the differentiating field 
(Lobjois et al, 2008). 
With respect to apoptosis, neural progenitors with low Sox5 levels presented up to a 
2.4-fold increase in cell death when assessed by Cas3* expression and by the 
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visualization of pyknotic nuclei (Fig 3G). It is possible that cells forced to proliferate 
when Sox5 expression is compromised initiate apoptosis while going through the G2/M 
phases. In neural tubes coexpressing Bcl2 and pRFPRNAi-Sox5, we observed a 51% 
increase in the ratio of cells accumulated in G2/M with respect to control neural tubes 
by flow cytometry analysis (supplementary Fig 3C,D). Altogether, this suggests that 
neural progenitors with reduced Sox5 expression are maintained for longer in a 
proliferative state and a fraction of them die by apoptosis.  
In summary, Sox5 negatively regulates cell cycle progression and it is necessary and 
sufficient to promote cell cycle arrest at the G1-S transition. 
 
Sox5 induces cell cycle exit by interfering with β-catenin transcriptional activity 
The Wnt/β-catenin signalling pathway favours neural tube progenitor proliferation 
directly controlling the transcription of the cell cycle regulators CyclinD1 and Nmyc 
(Tetsu & McCormick, 1999; ten Berge et al, 2008; Fig 4A-B).  
To test whether Sox5 could control cell cycle exit by interfering with the Wnt/β-
catenin pathway, we electroporated Sox5 together with a more stable form of β-catenin 
(β-cateninCA; Tetsu & McCormick, 1999), lacking one of the four phosphorylation sites 
that mediate Axin/APC complex binding and degradation. As expected, neuroepithelial 
cells with β-cateninCA displayed a higher proportion of cells in G2/M with respect to the 
control (supplementary Fig 4A,B). The expression of Sox5HIGH reverted this situation, 
causing a 33% reduction in the ratio of progenitors in G2/M phases with respect to cells 
expressing β-cateninCA alone (supplementary Fig 4B,C). Moreover, the increase in 
CyclinD1 and Nmyc expression mediated by β-cateninCA was prevented in a cell 
autonomous manner (n=3; asterisk versus arrow in Fig 4E). Additionally, CyclinD1 was 
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expressed in adjacent non electroporated cells probably by the induction of soluble 
signals coming from the cells electroporated with Sox5. 
Conversely, knocking down Sox5 expression provoked a further 14% increase in the 
ratio of cells in the G2/M phase with respect to cells expressing β-cateninCA alone 
(supplementary Fig 4D). Thus, in neural progenitors with reduced Sox5 levels, the 
proliferative potential of the Wnt pathway is reinforced.  
Next, we determined that Sox5-induced changes in gene expression (Fig 4A-H) 
were due to alterations in the Wnt canonical pathway activity as we observed a 51±15% 
decrease in the levels of the dephosphorylated active form of β-catenin (Fig 4I) in 
Sox5HIGH cells with respect to control cells. Surprisingly, using the TOPFLASH reporter 
of Wnt/β-catenin transcriptional activity, in neural tube cells, we observed that Sox5 
acted synergistically with β-cateninCA increasing Tcf reporter activity by 3.4 folds 
respect to β-cateninCA alone (supplementary Fig 5).  
In order to conciliate these apparently opposing results, we analysed the 
transcription of negative regulators of the Wnt pathway such Axin2, (Leung et al, 2002). 
Using the luciferase reporter system under the control of 1kb of the Axin2 promoter 
(with a functional Tcf binding site; Leung et al, 2002), we found that Sox5 acted 
synergistically with β-cateninCA increasing Axin2 promoter activity by 3.3 folds respect 
to β-cateninCA alone (Fig 4J). In fact, this Sox5 function is dependent on the Tcf binding 
site in the Axin2 promoter (Fig 4J). Furthermore, Axin2 was overexpressed in the dorsal 
progenitors expressing Sox5HIGH alone (Fig 4H) and/or with β-cateninCA (Fig 4G,C) in 
relation to control (Fig 4D). In conclusion, Sox5 enhances Tcf/β-catenin activity on the 
transcription of Axin2 in neural progenitors.  
The increased levels of Axin2 could mediate the reduction in the active form of β-
catenin observed in these cells and consequently downregulate expression of CyclinD1 
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and Nmyc, leading to cell cycle exit (Fig 4K). Obviously, Axin2 transcription would also 
be affected by the reduction in the active form of β-catenin. A plausible interpretation 
for the elevated levels of Axin2 mRNA would be that Sox5 could be 
enhancing/stabilizing Tcf /β-catenin transcriptional activity preferentially in the context 
of the Axin2 promoter, compensating for the reduction in active β-catenin. There are 
examples of Sox genes, such as Sox4, that enhances Tcf/β-catenin activity and may 
function to stabilize β-catenin (Sinner et al, 2007). We can not exclude that in the 
context of CyclinD1 or Nmyc promoter Sox5 could reduce the Tcf/ β-catenin activity, as 
the same Sox protein can exert a different transcriptional modulation in distinct genes 
and also depending on a given developmental scenario (Wegner & Stolt, 2005). 
 
Downregulation of Sox5 expression is required for the progression of dorsal 
interneuron differentiation  
Proliferation and differentiation are highly coordinated events that can be uncoupled on 
occasion. To determine whether this was the case following Sox5 premature expression, 
specific markers of dorsal and ventral interneurons were analysed (Jessell, 2000). 
Neural progenitors with Sox5HIGH generated neurons that prematurely expressed Lhx1/5 
(dI2,4,6 dorsal and V0,2 ventral interneurons; Martí et al, 2006), before reaching the 
mantle zone (n=4/8; Fig 5B). Moreover, they ectopically expressed the cell cycle 
inhibitor p27kip1+ (n=3; Fig 5C-D). However, there was a drastic reduction in Lhx1/5+ 
interneurons located in the mantle zone 24 hours (n= 8/8; Fig 5B) and 48 hours after 
maintaining Sox5HIGH (54±5% remained; n= 4; Fig 5E,F,K). A similar reduction was 
observed for Brn3a+ interneurons (dI3,5; 49±10%; n=3; Fig 5K), and for the En-1+ V1 
interneurons (38±19%; n=4; Fig 5K). More dramatically, only 13±4% of the Isl1/2+ 
interneurons (dI3) remained (n=3; Fig 5K). Reducing apoptosis with the anti-apoptotic 
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protein Bcl2 did not significantly recover the reduced populations of Lhx1/5+ and 
Brn3a+ interneurons, and only partially rescued that of Isl1/2+ interneurons (35±7% 
remained; supplementary Fig 6A-E). In conclusion, progenitors with Sox5HIGH were 
forced to exit the cell cycle, generated neurons that prematurely expressed 
differentiation markers and around half of neurons fail to complete the differentiation 
program.  
On the other hand, it has been shown that forcing progenitors to continue to cycle 
does not prevent cells from differentiating into the right cell type (Dyer & Cepko, 2000; 
Lobjois et al, 2008). In fact, knocking down Sox5 levels does not alter the hemitube 
thickness and only mildly alters the gross pattern of differentiation, as it slightly 
reduced the number of Lhx1/5+ interneurons (16% reduction; n=5; Fig 5G,L) and 
reduced the number of the small population of Isl1/2+ dI3 interneurons (by 82%; n=3; 
Fig 5 I,L). The reduction in the number of Lhx1/5+ and Isl1/2+ neurons was totally 
rescued by Bcl2 protein (Fig 5H,J,L). As the apoptosis is not fully overcome by Bcl2 
expression (supplementary Fig 3D), these results would suggest that progenitors with 
reduced levels of Sox5 remain cycling for longer and probably generate an increased 
number of Lhx1/5+ differentiated interneurons, similar to CyclinD1-transfected neural 
progenitors (Lobjois et al, 2008). The possible excess of Lhx1/5+ interneurons would 
have been overcompensated by apoptosis. 
In summary, these results suggest that: i) Sox5 is sufficient to induce premature cell 
cycle exit but it prevents the progression of the interneurons differentiation program; ii) 
Sox5 is required for the timing of cell cycle exit and for the correct final number of 
dorsal interneurons and iii) Sox5 is essential for the survival of dI3 interneurons, that 
normally express high level of Sox5.  
 10
Our data establish, for the first time in a neural context, both the role of a Sox 
transcription factor in the timing of cell cycle exit and in the modulation of the Wnt/β-
catenin pathway to control that function. By increasing the levels of the negative 
regulator Axin2, Sox5 would control the feedback repressor pathway regulating Wnt 
signalling (Leung et al, 2002).  
Several Sox proteins fulfil crucial roles in the context of neurogenesis. SoxB1 
promote progenitor cell maintenance (Bylund et al, 2003) while SoxB2 promote the 
onset of neuronal differentiation (Sandberg et al, 2005). Our studies assign a role for 
Sox5 between the activity of SoxB1 and SoxB2 proteins, since Sox5 promotes cell 
cycle exit of neural progenitors and its downregulation is required for the progression of 
neuronal differentiation.  
 
METHODS 
Chick in ovo electroporation. Embryos were electroporated at HH10-13 and processed 
24 hours PE (HH14-17) or 48 hours PE (HH19-22) as previously described (Perez-
Alcala et al, 2004), using immunohistochemistry, in situ hybridization, western blot, 
FACS or luciferase assays. 
Fluorescent associated cell sorting (FACS). Electroporated neural tubes, carrying 
GFP as reporter, were dissociated into single cell suspension 24-48 hours later as 
previously described (Cayuso et al, 2006). Nuclei were labelled with Propidium Iodide 
to estimate DNA content in GFP+ cells. Flow cytometry data was collected and 
multiparameter analysis was performed in an EPICS XL Coulter Cytometer (Beckman 
Coulter).  
Luciferase reporter assay. Transcriptional activity assays were performed in embryos 
electroporated with the indicated DNAs, together with a 1 kb of Axin2 promoter in a 
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luciferase reporter construct (Leung et al, 2002) or the TOPFLASH containing synthetic 
Tcf-binding sites (Korinek et al, 1998) and two Renilla luciferase reporter constructs 
carrying the CMV and the SV40 promoter each (Promega) for normalization. Luciferase 
activities were measured by the Dual Luciferase Reporter Assay System (Promega).  
Statistical analysis. All data presented here are number of cells in the electroporated 
area that expresses a marker respect to the cells expressing the same that marker in an 
equivalent area in the non electroporated side (% cells+ EP/cells+ C). Quantitative data 
were expressed as mean ±s.d. or SEM.; n≥3 embryos per experimental point. Significant 
differences were tested by Student’s test.  
Supplementary information is available at EMBO reports online. 
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LEGENDS TO FIGURES  
Fig 1 | Expression of Sox5 in the developing chick spinal cord. (A) At stage HH10, 
Sox5 is expressed dorsally in neural crest cells and in floor plate cells. (B) At stage 
HH14, Sox5 is expressed by the majority of the neuroepithelial cells. (C,D) Sox5 
expression at HH24 is absent from most of the HuC/D differentiating interneurons. (E, 
F) Sox5 is co-expressed in dorsal neural progenitors with Pax7. (G-I) A subpopulation 
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of dorsal dI3 interneurons co-expresses Sox5 and Islet1/2 (arrows). (J-L) At HH24, 
Sox5 is expressed in a subpopulation of Isl1/2+ motoneurons (arrows).  
 
Fig 2 | Forced Sox5 expression promotes cell cycle exit. Sox5 misexpression (pCIG-
Sox5; GFP green on right side; E-H’) in HH14-16 embryos caused a 30% reduction in 
the size of the hemitube (E), in the number of BrdU (F,F’) and pH3 positive cells (G, 
G’) and an increase in Cas3* positive dying cells (I) in relation to control pCIG 
embryos (A-C’). Expression of the neural progenitors maker Pax6 is not altered in 
Sox5HIGH cells (H, H’, D,D’). (I) Quantification of the effect 24 or 48 hours PE. (*) 
p<0.01; (**) p<0.005; (***) p<0.001. (H) Cumulative BrdU labelling curves of pCIG 
(black squares) or pCIG-Sox5 (red circles) electroporated neural tube cells. Dashed 
lines indicate the reduction in growth fractions. Mean of three embryos per 
experimental point, s.d. and t test was calculated; (***) p<0.01; (**) p<0.025; (*) 
p<0.05  
 
Fig 3 | Sox5 is necessary to control the timing of cell cycle exit. (A-G) Stage HH22, 
embryos analysed 48 hours PE. (A-B’) Sox5 specific shRNA (pRFPRNAi-Sox5, mi2) 
decreases a 66% the endogenous levels of Sox5 protein (B,B’) in relation to a 
pRFPRNAi-control (A,A’). (C-G’) Knocking down Sox5 expression with mi2 increases 
the number of BrdU (D,D’) and PH3 (F, F’) positive cells respect to control 
(C,C’,E,E’). Few proliferating RFP/PH3 double positive cells are misallocated in the 
differentiated cell area (arrows in F, inset in F’). (G) Quantification of the effects using 
two different shRNAs, mi1 and mi2. (*) p<0.05; (**) p<0.025; (***) p<0.01; n.s. not 
significative. (H,-I’) Sox5 overexpression decreases CyclinD1 expression at HH14 
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(asterisk in H) while reduction of Sox5 levels induces CyclinD1 expression at HH18 
(arrow in I,I´).  
 
Fig 4 |Sox5 interferes with β-catenin transcriptional activity in the control of Axin2 
expression. (A-J) Stage HH14-16 embryos analysed 24 hours post electroporation. 
Activation of the canonical Wnt pathway by overexpressing a stabilized form of β-
catenin (pCIG-β-cateninCA) promotes an upregulation of CyclinD1 (arrow in A,A’), 
NMyc (B,B’) and Axin2 expression (C,C’). Forcing Sox5 expression together with 
pCIG-β-cateninCA represses CyclinD1 (asterisk versus arrow in E,E’) and NMyc (F,F’) 
expression and induces Axin2 expression (G,G’). Sox5HIGH alone also induces Axin2 
expression (D,D’ compared to H,H’) . (I) Sox5 overexpression reduces to a 49% the 
levels of active β-catenin (β-cat*) relative to those in pCIG electroporated cells. Values 
were normalized using αtubulin as a reference (αtub). (*) p<0.005. (J) Quantitative 
analysis of the transcriptional activity of Sox5 alone or in combination with β-cateninCA 
on an intact Axin2 promoter (light bars) or on a Tcf binding site mutated one (dark 
bars). Graphs show normalized luciferase units relative to the pCIG control. Each bar 
represents mean ± SEM of triplicate experiments. (**) p<0.001. (K) Model for Sox5 
action on Wnt signalling pathway in the spinal cord (see main text). 
 
Fig 5 | Downregulation of Sox5 expression is required for the progression of dorsal 
interneuron differentiation. (A-D’) Sustained elevation of Sox5 in HH14-16 embryos 
induces ectopic activation of Lhx1/5 (arrows, B,B’) and p27kip1 (arrows in D,D’) in 
neurons before they reach the mantle zone, with respect to control pCIG cells 
(A,A’,C,C’). (E,F,K) At stage HH18-22, there was a reduction in the number of 
Lhx1/5+ (F,F’), Brn3a+, En1+ and Isl1/2+ interneurons (K). (G,I,L) At stage HH18-22, 
 16
 17
knocking down Sox5 expression (mi2, red) affects the number of Lhx1/5+ (G,G’,L) and 
Isl1/2+ interneurons (I,I’,L). (H-J,L) Coelectroporation with Bcl2 rescues the total 
number of Lhx1/5+ (K) and Isl1/2+ interneurons (brackets in L) Quantification of the 
number of cells expressing a given neuronal marker 48 hours PE with the indicated 
construct. (*) p<0.05; (**) p<0.003; (***) p<0.001. 
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SUPPLEMENTARY METHODS 
Constructs. Chicken Sox5 coding sequence (Perez-Alcala et al, 2004) and a mutant β-
catenin where serine 33 is replaced by tyrosine, impeding the phosphorylation necessary 
for degradation (β-cateninCA, Tetsu & McCormick, 1999), were inserted into pCIG 
(Niwa et al, 1999), that includes an IRES, and EGFP as reporter (pCIG-Sox5, pCIG- β-
cateninCA). A human Bcl2-coding sequence inserted into pCDNA3 was used for co-
electroporation (Cayuso et al, 2006). Four different 22 nt target sequences for cSox5 
were chosen to generate short hairpin miRNAs and they were inserted into the 
pRFPRNAi vector that contains a chicken microRNA operon and dsRFP as reporter 
gene (pRFPRNAi-Sox5; Das et al, 2006). Two of these shRNAs consistently blocked 
Sox5 expression (mi1, nt 1668-1689; mi2, nt 2049-2070). As a control, a 22nt target 
sequence based on the luciferase coding sequence was used to generate short hairpin 
miRNA specific for luciferase (pRFPRNAi-Control; Das et al, 2006). 
 
Chick in ovo electroporation. Eggs from White-Leghorn chickens were incubated at 
38.5ºC in an atmosphere of 70% humidity. Embryos were staged according to 
Hamburger and Hamilton (HH; Hamburger & Hamilton, 1951). 
Chick embryos were electroporated with Quiagen purified plasmid DNA at 1-2 
ug/ul in PBS with Fast Green (50 ng/ml), as described previously (Pérez-Alcalá et al, 
2004). Briefly, plasmid DNA was injected in the lumen of HH10-13 neural tubes, 
electrodes were placed on either side of the neural tube and a train of electric pulses (5 
pulses, 14 volts, 50 msec) was applied using an electroporator (Intracel TSS20). Eggs 
were further incubated for 24 to 48 hours and they were assayed for EGFP or DsRed 
expression in the neural tube. The embryos were processed for immunohistochemistry , 
in situ hybridization, western blot or luciferase transcriptional assays.  
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 Immunohistochemistry. Embryos were fixed for 2-4 hours at 4ºC with 4% 
paraformaldehyde in PBS, and they were immersed in 30% sucrose solution, embedded 
in OCT and sectioned on a Leica cryostat. Alternatively, embryos were embedded in 
agarose/sacarose (5%/10%) and they were sectioned in a Leica vibratome (VT1000S). 
Immunostaining was performed as described previously (Pérez-Alcalá et al, 2004). 
For BrdU detection, sections were incubated in 2N HCl for 30 minutes and then in 
0.1 sodium borate [pH 8.5], before they were exposed to anti-BrdU antibodies. Primary 
antibodies against the following proteins were used: Sox5 (Pérez-Alcalá et al, 2004); 
green fluorescence protein (GFP; Molecular Probes); phospho-Histone 3 (pH3; Upstate 
Biochemicals); caspase 3* (BD); HuC/D (Molecular Probes); Brn3a (Chemicon); p27 
(Transduction lab). Monoclonal antibodies against BrdU (G3G4), Lhx1/5 (4F2), Pax6, 
Pax7 and Islet1/2 were all obtained from the Developmental Studies Hybridoma Bank 
(developed under the auspices of NICHD and maintained by the University of Iowa). 
Alexa 488- and Cy3-conjugated anti-mouse or anti-rabbit secondary antibodies 
(Molecular Probes) were used for detection and after staining, the sections were 
mounted in Citifluor (Citifluor Ltd., Leicester, UK) plus Bisbenzimide and photograph 
using a Leica confocal microscope. Cell counting was carried out in 4-8 sections of at 
least three different embryos from each experimental condition. In the case of BrdU 
staining, 16-24 optical sections per embryo were counted. The levels of Sox5 protein 
were measured using the programme Image J [125-175 cells from 5-7 optical sections 
(25 cells per section) of 3 different embryos for each experimental condition]. 
 
S-Phase Labeling and calculation of cell cycle parameters. Cumulative BrdU 
labeling was carried out by repeated injections of BrdU (5 µg/µl; Sigma) at 2.5 hr 
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intervals for a total of 1,2, 3, 6, 9, or 12 hr. Calculation was performed by nonlinear 
regression analysis of BrdU labeling index (percentage of  nuclear GFP+ cells that were 
BrdU+, 1.0 labeling index = 100%) after counting 9-12 confocal sections from at least 
three embryos for experimental point. Excel spreadsheet was kindly provided by Dr. 
Richard S. Nowakowski (Nowakowsky et al, 1989). In brief, the intercepts of the best 
nonlinear fit with the abscissa (y) and the time (z) needed to reach the maximum 
labeling index (growth fraction= GF) correspond to the (1) length of S (TS) relative to 
the cell cycle (TC) and (2) TC-TS, respectively, allowing us to solve the equations: Tc-
Ts = z; (Ts/Tc)GF = y. 
 For short pulses of BrdU labelling, BrdU was injected into the neural tube 40 
minutes prior to fixation. 
 
Fluorescent associated cell sorting (FACS). HH11-13 electroporated neural tubes, 
carrying GFP as reporter, were dissected out 24-48 hours later and a single cell 
suspension was obtained after 20 min incubation in Trypsin (Worthington, Lakewood, 
NJ), followed by a 30 minute fixation in 2% paraformaldehyde as previously described 
(Morales et al, 1998). At least three independent experiments with three separately 
treated embryos were analysed by FACS for each experimental condition. Dissociated 
cells were exposed to RNAse A (25 µg/µl) and the nuclei were then labelled with 
Propidium Iodide (25 µg/µl) to estimate DNA content in GFP+ cells. Flow cytometry 
data was collected and a multiparameter analysis was performed in an EPICS XL 
Coulter Cytometer (Beckman Coulter) with a 488 nm excitation laser, a 525 nm 
emission filter for GFP and 620 nm emission filter for Propidium Iodide. 
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In situ hybridization. Embryos were fixed overnight at 4ºC with 4% paraformaldehyde 
in PBS, rinsed and processed for whole-mount in situ hybridization as described 
previously (Perez-Alcalá et al, 2004). The chick CyclinD1 and Nmyc riboprobes have 
been described elsewhere (Megason and McMahon, 2002; Sawai et al, 1990) and Axin2 
cDNA was obtained from the chicken EST project, UK-HGMP RC. Three to seven 
embryos were analysed for each experimental condition. The probe hybridization was 
detected with alkaline phosphatase–coupled anti-digoxigenin Fab fragments (Roche). 
Hybridized embryos were postfixed in 4% paraformaldehyde, vibratome sectioned and 
immunostained as described above to visualize GFP+ electroporated cells. 
 
Immunoblot analysis. SDS-8% polyacrylamide gels were calibrated with molecular 
weight markers (Bio-Rad), and polyclonal anti-SOX5 (Perez-Alcala et al, 2004), 
monoclonal anti-α-tubulin (Promega)  and monoclonal β-catenin specific to active form, 
dephosphorilated on ser37 or Th41(Millipore). Two secondary antibodies (horseradish 
peroxidase-conjugated, anti-mouse and anti-rabbit) were each used. Bound antibodies 
were visualized by chemiluminescence using the ECL Advance Western Blotting 
Detection Kit (Amersham), and luminescent images were obtained by a LuminoImager 
(AGFA). 
 
Luciferase-reporter assay. Transcriptional activity assays of distinct components of 
the β-catenin/Tcf pathways were performed in chick embryos electroporated at HH12-
13 stage with the indicated DNAs cloned into pCIG or with empty pCIG vector as 
control, together with a 1 kb of Axin2 promoter in a luciferase reporter construct (Leung 
et al, 2002) or the TOPFLASH containing synthetic Tcf-binding sites (Korinek et al, 
1998; Upstate) or the same promoters with one or six Tcf-binding sites mutated, 
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respectively  and two Renilla luciferase reporter constructs carrying the CMV and the 
SV40 promoter each (Promega) for normalization. Embryos were harvested after 24 
hours incubation in ovo and GFP positive neural tubes were dissected and homogenized 
in Passive Lysis Buffer. Firefly- and renilla-luciferase activities were measured by the 
Dual Luciferase Reporter Assay System (Promega).  
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LEGENDS TO SUPPLEMENTARY FIGURES 
 
SFig 1 | Coelectroporation of Bcl2 decrease the levels of apoptosis induced by pCIG 
and pCIG-Sox5 electroporation. (A,A’,D,D’) Sox5 misexpression (pCIG-Sox5; GFP 
green on right side; D,D’) in HH14-16 embryos caused a 260% increase in Cas3* 
positive dying cells in relation to control pCIG embryos (A,A’). (B-C’,E-F’) 
Coelectroporation with Bcl2 reduce the number of apoptotic cells 24 and 48 hours 
postelectroporation. (I) Quantification of the effect after 24 or 48 hours post 
electroporation. (*) p<0.05, (**) p<0.002, (***) p<0.001; n.s. not significant difference.  
 
 
SFig 2 | Sox5 induces accumulation of cells in G0/G1. (A-D) Flow cytometry 
analysis of the cell cycle phase distribution 24 hours after electroporation with the 
indicated construct. The DNA content was analysed by Propidium Iodide staining in 
GFP+ cells. In control conditions, 45% of cells expressing GFP were in the G0/G1 phase 
of the cell cycle (2N DNA content), 22% in S-phase (intermediate DNA content) and 
34% in G2/M phase (4N DNA content; Fig. 2L). Upon Sox5 missexpression there was a 
23% increment of cells in G0/G1 (B) with respect to the control (A)[ from 45% to 55% 
of cells in G0/G1 the ratio of increase is calculated as (55-45)x100/45]. Sox5 HIGH 
expression in embryos with reduced levels of apoptosis (+Bcl2) showed a 38%increase 
in the rate of cells accumulated in G0/G1 (D), respect to the control (C).  
 
SFig 3 | Sox5 is necessary to control cell cycle exit. (A) A Sox5 specific shRNA 
(pRFPRNAi-Sox5-mi2) decreased the endogenous levels of Sox5 protein to a 34% in 
relation to a pRFPRNAi-control 48 hours after electroporation. (B,C) Two different 
Sox5 shRNA (pRFPRNAi-Sox5-mi1 and-mi2) promote a similar reduction in the levels 
of Sox5 protein in neural progenitors. (D) Coelectroporation of Bcl2 decreases the 
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levels of apoptosis induced by pRFPRNAi-Control and pRFPRNAi-Sox5, mi2 
electroporation.  (E,F) Flow cytometry analysis of cell cycle phase distribution of cells 
electroporated with pRFPRNAi-Control (E) or pRFPRNAi-Sox5, mi2 (F), in 
combination with pCIG and the survival factor Bcl2. Knocking down Sox5 levels, in 
embryos with elevated levels of Bcl2, caused a 51% increase in the ratio of cycling cells 
in the G2/M phases (F), with respect to the control electroporated embryos (E). 
(**)<0.001, (*)<0.05. 
 
SFig 4 | Sox5 promotes cell cycle arrest by interfering with β-catenin proliferating 
activity. (A-D) Flow cytometry analysis of cell cycle progression in cells transfected 
with the indicated constructs. pCIG-β-cateninCA promotes a 41% increase in the 
proportion of neuroepithelial cells in G2/M (B) compared with cells transfected with 
pCIG (A). However, elevated levels of Sox5 expression blocked the proliferative effect 
of β-cateninCA (a 33% decrease in the ratio of cells in G2/M phases in relation to of cells 
with β-cateninCA alone) (C). Conversely, the loss of Sox5 protein in neuroepithelial 
cells with β-cateninCA potentiates the proliferative effect: a 14% increase in cells in 
G2/M with respect to cells expressing β-cateninCA alone (D) and a 60% respect to pCIG 
transfected cells (A).  
 
SFig 5 | Sox5 interferes with β-catenin transcriptional activity in the spinal cord.(A) 
Quantitative analysis of the transcriptional activity of Sox5 alone or in combination 
with β-cateninCA on a Tcf (TOPFlash) transcriptional reporter in HH11-3 electroporated 
neural tubes. Mutations in the six Tcf binding sites (FOPFlash construct) completely 
abolished the transcriptional activity induced by β-cateninCA, Sox5 or the combination 
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of them both in neuroepithelial cells of the neural tube (data not shown). Graphs show 
normalized luciferase units relative to the pCIG control.  
 
SFig 6 | Preventing apoptosis is not sufficient to rescue the decrease in the number of 
Sox5HIGH differentiated neurons. (A-D’) After 48 hours PE, cells with Sox5HIGH 
coexpressing the anti-apoptotic protein Bcl2 failed to differentiate as Lhx1/5+ (49% 
decrease; C,C’) and  Isl1/2+ dI3 (65% decrease; D,D’) interneurons with respect to 
pCIG transfected cells (A-B’). (E) Quantification of the number of cells expressing a 
given neural marker 48 hours PE with the indicated construct. (*) p<0.02; (**) p<0.004; 
(***) p<0.001. 
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